Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes fromFinra
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Gilead Sciences isn't betting its 2021 on coronavirus treatment Veklury. But the biotech company still sees plenty of catalysts in oncology, virology and inflammation for Gilead stock.
Pfizer Inc has been holding onto second doses for each of its COVID-19 vaccinations and anticipates no problems supplying them to Americans, a spokeswoman said in a statement on Friday. Pfizer has shipped more than 15 million doses to destinations around the U.S. from its Michigan facility and expects to be able to produce around 2 billion doses worldwide in 2021, the spokeswoman said, adding that U.S. health officials recently asked the company to begin distributing its second doses.
U.S. drugs firm Pfizer has told Italy it will cut its deliveries of vaccine shots against the novel coronavirus by 29% starting from Monday, the country's COVID-19 special commissioner Domenico Arcuri said. Arcuri said Pfizer had informed Rome it was not able to foresee for how long it would be curtailing its supplies compared to what had been planned and by how much. Arcuri said he had complained to Pfizer given the "seriousness and the unbelievable timing" of the communication received, and wo...
Suzanne Judd, Ph.D., Epidemiologist at the University of Alabama at Birmingham School of Public Health, joins Yahoo Finance's Sibile Marcellus to break down the latest coronavirus developments.
U.S. pharmaceutical company Pfizer confirmed Friday it will temporarily reduce deliveries to Europe of its COVID-19 vaccine while it upgrades production capacity to 2 billion doses per year.
Pfizer's re-tooling of its vaccine output procedures will slow non-U.S. deliveries in the coming weeks, but the drugmaker said the changes will allow it to deliver 2 billion doses by the end of the year.
Novavax is making a play for a coronavirus vaccine, vs. giants like Pfizer, and other rivals like Moderna. But NVAX stock has been volatile. Is Novavax stock a buy right now?
The European Union's chief executive said on Friday she had spoken to Pfizer and been reassured that scheduled COVID-19 vaccine deliveries will be made in the first quarter of 2021, despite current delays. "Like many of you, I got the news today that Pfizer announced delays, I immediately called the CEO of Pfizer ... he reassured me that all guaranteed doses of the first quarter will be delivered in the first quarter," European Commission President Ursula von der Leyen told a news conference.
President-elect Joe Biden released a $1.9 trillion COVID-19 response plan on Thursday evening, setting goals for his first 100 days in office, including a call for 100 million vaccinations by then.
Some EU nations are receiving fewer than expected doses of coronavirus vaccines as U.S. pharmaceutical firm Pfizer slows shipments, while Turkey and China race ahead with inoculations amid surging infections worldwide. Six EU countries described the delay as unacceptable and said it impacted the credibility of the whole vaccination process. Spooked by a fast-spreading variant first detected in Britain, governments in Europe have imposed tighter and longer lockdowns and curbs.